Skip to main content
Log in

Screening for nonvalvular AF cost effective in elderly adults

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2016 US dollars

Reference

  • Oguz M, et al. Cost-Effectiveness of Extended and One-Time Screening Versus No Screening for Non-Valvular Atrial Fibrillation in the USA. Applied Health Economics and Health Policy : 17 Dec 2019. Available from: URL: https://doi.org/10.1007/s40258-019-00542-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Screening for nonvalvular AF cost effective in elderly adults. PharmacoEcon Outcomes News 844, 39 (2020). https://doi.org/10.1007/s40274-020-6502-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6502-5

Navigation